Skip to content

Comparison of efficacy of steroids versus platelet rich plasma in to the shoulder joint under ultra sonographic guidance on patients with severe shoulder joint pain

Comparison of efficacy of ultrasound guided bursal injection of triamcinolone compared to autologous platelet rich plasma in improving pain and range of motion in shoulder impingement syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2015/016
Enrollment
Unknown
Registered
2015-09-04
Start date
2015-09-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder impingement syndrome

Interventions

The study will be carried out at the Teaching Hospital, Peradeniya. Consenting participants meeting inclusion/exclusion criteria will be allocated into two arms using block randomization technique. T

Sponsors

University of Peradeniya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males and females between 30-70 years of age 2. Clinical diagnosis of shoulder impingement (SI) (Neer’s stages 1 and 2) with anterolateral shoulder pain for more than 3 months

Exclusion criteria

Exclusion criteria: 1. Full thickness rotator cuff tears [type III impingement] 2. Other pathological conditions giving pain in the shoulder such as arthropathies [Rheumatoid, osteoarthritis, septic arthritis] 3. Cervical neuropathy 4. Intra articular steroid injection within last 6 months 5. Local or systemic infection 6. Coagulopathies 7. Critical thrombocytopaenia 8. Hypofibrinogenaemia 9. Increased fasting blood glucose levels [ more than 10 mmol/L] or poorly controlled diabetes mellitus 10. Pregnancy

Design outcomes

Primary

MeasureTime frame
1. Angle of shoulder abduction at which pain is elicited, measured using a standardized goniometer 2. Degree of pain will be assessed using a standardized pain score [At baseline (before injection), then at the end of 1 week, 3 months, 6 months and 1 year]

Secondary

MeasureTime frame
None [None]

Countries

Sri Lanka

Contacts

Public ContactProf P B Hewavithana

Professor in Medicine

padmabh@pdn.ac.lk0812396551

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026